Molina Healthcare reports FY23 MCR 88.1%

The company states: “The consolidated MCR for the full year 2023 was 88.1%, consistent with expectation and in line with the Company’s long-term target range. The Medicaid MCR for the full year 2023 was 88.7%, in line with the Company’s expectation and long-term target range. The full year MCR includes the moderate impact from the net effect of redetermination acuity shifts and risk corridors, as well as the impact of new store additions which typically run above portfolio average in the first year. The Medicare MCR for the full year 2023 was 90.7%, above the Company’s long-term target range, reflecting higher utilization of supplemental benefits, in-home services, and high-cost drugs throughout the year. The Marketplace MCR for the full year 2023 was 75.3%, below the Company’s long-term target range, reflecting the success of the Company’s product and pricing strategy to return the business to target margins. “